JPRN-UMIN000011829
Completed
Phase 2
Safety and efficacy of intra-articular injections of platelet-rich plasma for the treatment of osteoarthritis of the knee in the Japanese population - Safety of platelet-rich plasma for the treatment of osteoarthritis of the knee
niversity of Tsukuba Hospital0 sites10 target enrollmentStarted: October 1, 2013Last updated:
ConditionsOsteoarthritis of the knee
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- niversity of Tsukuba Hospital
- Enrollment
- 10
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Requiring infiltration in both knees 2\. BMI more than 33 3\. Suffering from polyarticular disease 4\. Previous knee arthroscopy within last year 5\. HA or steroid intra\-articular infiltration within last 3 months 6\. Past history of infectious disease 7\. Compromised host 8\. Systemic autoimmune disease 9\. Anemia with hemoglobin under 10g/dl 10\. Blood disorders 11\. Treatment with anticoagulant drugs (Aspirin, Warfarin) 12\. Having undergone treatment with steroids during 3 months before inclusion in this study 13\. Treatment with NSAIDs during 2 weeks before its inclusion in this study 14\. Patients who had malignancy during 5 years before inclusion in this study 15\. Patients who do not have a voluntary consent capacity 16\. Patients who cannot have a consent with document 17\. Patients whom the doctor has determined that it is not suitable for this clinical study
Investigators
Similar Trials
Completed
Not Applicable
The efficacy and safety of intra-articular injections with the tumour-necrotising factor alpha (TNFa) antagonist infliximab in patients with chronic or recurrent arthritis of the kneeArthritis, spondyloarthropathy, rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisISRCTN17726268eiden University Medical Centre (LUMC) (The Netherlands)40
Recruiting
Not Applicable
The efficacy and safety of intra-articular injections with the TNF-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.recurrent or persistent inflammatory arthritis involving a knee (rheumatoid arthritis, juvenile chronic arthritis, spondylarthropathies and arthritis of unknown origin) despite corticosteroid injections intra-articularNL-OMON24235department of rheumatologyLeids Universitair Medisch CentrumPostbus 9600 RC Leiden40
Active, not recruiting
Phase 1
Efficacy and safety of 3 intra-articular injections of 500 µg icatibant in a randomized, double-blind, parallel-group, placebo-controlled 13-week multi-centre study in patients with symptomatic knee osteoarthritis, continued by an observation of safety and tolerability over a further double-blind 13-week period - NApatients with painful OA in the kneeEUCTR2006-005946-35-SKsanofi-aventis recherche & développement450
Completed
Not Applicable
Safety and performance of the intra-articular injection of animal-free chitosan biomaterial (viscosupplementation) in patients with symptomatic knee osteoarthritis: a pre-market studyArtrosisOsteoarthritis10023213NL-OMON48771KiOmed PHARMA SA35
Recruiting
Phase 2
The effectiveness of Hyaluronic acid/Chondroitin injection on knee performance after surgical fixation.IRCT20170608034390N13Shahid Beheshti University of Medical Sciences32